Home
ABOS
ABOS News

Latest Acumen Pharmaceuticals Inc. (ABOS) News on July 26, 2024

MT Newswires

12 hours ago

Citigroup Starts Acumen Pharmaceuticals With Buy Rating, $7 Price Target

Acumen Pharmaceuticals to Present Patient Experience and Biomarker Insights from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

GlobeNewswire

15 days ago

Acumen Pharmaceuticals to Present Patient Experience and Biomarker Insights from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?

Insider Monkey

a month ago

Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?

GuruFocus.com

2 months ago

Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Acumen Pharmaceuticals Inc Earnings Call

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

2 months ago

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire

2 months ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

MT Newswires

2 months ago

Arthur J. Gallagher Acquires Acumen Advisors

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

GlobeNewswire

3 months ago

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

MT Newswires

3 months ago

Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease

GlobeNewswire

3 months ago

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

GlobeNewswire

3 months ago

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By

Insider Monkey

3 months ago

12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

GlobeNewswire

3 months ago

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

Insider Monkey

4 months ago

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

Acumen Pharmaceuticals Collaborates with Lonza For Alzheimer’s Treatment

Exec Edge

4 months ago

Acumen Pharmaceuticals Collaborates with Lonza For Alzheimer’s Treatment

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease

GlobeNewswire

4 months ago

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease

Why Acumen Pharmaceuticals (ABOS) Stock Might be a Great Pick

Zacks

4 months ago

Why Acumen Pharmaceuticals (ABOS) Stock Might be a Great Pick

Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

4 months ago

Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Acumen Pharmaceuticals Inc Earnings Call

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

GlobeNewswire

4 months ago

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year?

Zacks

4 months ago

Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year?

Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting

GlobeNewswire

4 months ago

Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

GlobeNewswire

4 months ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

15 Best Anti-Aging Foods for Youthful Skin

Insider Monkey

4 months ago

15 Best Anti-Aging Foods for Youthful Skin

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

GlobeNewswire

4 months ago

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

GlobeNewswire

5 months ago

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

Zacks

5 months ago

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

Institutional investors own a significant stake of 42% in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Simply Wall St.

5 months ago

Institutional investors own a significant stake of 42% in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS)

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

GlobeNewswire

5 months ago

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

GlobeNewswire

6 months ago

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

InvestorPlace

6 months ago

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

PEOPLES FINANCIAL SERVICES CORP. Declares First Quarter 2024 Dividend

PR Newswire

6 months ago

PEOPLES FINANCIAL SERVICES CORP. Declares First Quarter 2024 Dividend

BrightView Publishes 2024 Corporate Responsibility Report

Business Wire

6 months ago

BrightView Publishes 2024 Corporate Responsibility Report

The Fed Tells Banks Not to Be Shy About Asking It for Money

Bloomberg

6 months ago

The Fed Tells Banks Not to Be Shy About Asking It for Money

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

6 months ago

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

BayCom Corp (BCML) Reports Decrease in Q4 Earnings Amidst Market Challenges

GuruFocus.com

6 months ago

BayCom Corp (BCML) Reports Decrease in Q4 Earnings Amidst Market Challenges

CORRECTION: Summit Financial Group Reports Earnings of $1.11 Per Share for Fourth Quarter 2023

GlobeNewswire

6 months ago

CORRECTION: Summit Financial Group Reports Earnings of $1.11 Per Share for Fourth Quarter 2023

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates

Zacks

6 months ago

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates

3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom

InvestorPlace

6 months ago

3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom

GuruFocus.com

6 months ago

FVCBankcorp Inc (FVCB) Reports Mixed Results Amidst Strategic Repositioning

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

PR Newswire

6 months ago

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

6 months ago

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Associated Press Finance

6 months ago

FVCBankcorp: Q4 Earnings Snapshot

FVCBankcorp, Inc. Announces 2023 Earnings

Business Wire

6 months ago

FVCBankcorp, Inc. Announces 2023 Earnings

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

Zacks

6 months ago

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

Kopin Receives Initial Production Order for Advanced Surgical Information Display

Business Wire

6 months ago

Kopin Receives Initial Production Order for Advanced Surgical Information Display

Associated Press Finance

6 months ago

RBB: Q4 Earnings Snapshot

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

Business Wire

6 months ago

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

17 Best Augmented Reality Stocks To Invest In

Insider Monkey

6 months ago

17 Best Augmented Reality Stocks To Invest In

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Insider Monkey

6 months ago

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

Zacks

6 months ago

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

Renovaro BioSciences Releases CEO Shareholder Message

NewMediaWire

6 months ago

Renovaro BioSciences Releases CEO Shareholder Message

Buy These 4 Low-Beta Stocks to Counter Market Volatility

Zacks

6 months ago

Buy These 4 Low-Beta Stocks to Counter Market Volatility

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Business Wire

6 months ago

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Kopin Corporation Unveils New Era of Innovation and Leadership Following NASDAQ Closing Bell Ceremony

Business Wire

6 months ago

Kopin Corporation Unveils New Era of Innovation and Leadership Following NASDAQ Closing Bell Ceremony

Is Now The Time To Look At Buying Canadian Solar Inc. (NASDAQ:CSIQ)?

Simply Wall St.

6 months ago

Is Now The Time To Look At Buying Canadian Solar Inc. (NASDAQ:CSIQ)?

Rackspace Technology Promotes Mark Marino to Chief Financial Officer

GlobeNewswire

6 months ago

Rackspace Technology Promotes Mark Marino to Chief Financial Officer

Caledonia Mining Corporation Plc: Blanket Mine Q4 and FY 2023 Production and 2024 Guidance

GlobeNewswire

6 months ago

Caledonia Mining Corporation Plc: Blanket Mine Q4 and FY 2023 Production and 2024 Guidance

3 Stocks to Profit from the Enormous Gig Economy

InvestorPlace

6 months ago

3 Stocks to Profit from the Enormous Gig Economy

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

Simply Wall St.

7 months ago

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS

GlobeNewswire

7 months ago

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS

The Zacks Analyst Blog Highlights JAKKS Pacific, Hooker Furniture, Netflix, Skillz and Acushnet

Zacks

7 months ago

The Zacks Analyst Blog Highlights JAKKS Pacific, Hooker Furniture, Netflix, Skillz and Acushnet

Zynex to Participate at the Needham Annual Growth Conference

PR Newswire

7 months ago

Zynex to Participate at the Needham Annual Growth Conference

J.Jill, Inc. Reaffirms Fourth Quarter and Full Year 2023 Guidance Ahead of the 26th Annual ICR Conference

Business Wire

7 months ago

J.Jill, Inc. Reaffirms Fourth Quarter and Full Year 2023 Guidance Ahead of the 26th Annual ICR Conference

SmartFinancial Sets Dates for Fourth Quarter Earnings Release and Conference Call

GlobeNewswire

7 months ago

SmartFinancial Sets Dates for Fourth Quarter Earnings Release and Conference Call

Is Daktronics a Buy Right Now?

Motley Fool

7 months ago

Is Daktronics a Buy Right Now?

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC

GlobeNewswire

7 months ago

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC

OUT vs. CCI: Which Stock Is the Better Value Option?

Zacks

7 months ago

OUT vs. CCI: Which Stock Is the Better Value Option?

Can Mixed Fundamentals Have A Negative Impact on Hamilton Beach Brands Holding Company (NYSE:HBB) Current Share Price Momentum?

Simply Wall St.

7 months ago

Can Mixed Fundamentals Have A Negative Impact on Hamilton Beach Brands Holding Company (NYSE:HBB) Current Share Price Momentum?

Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Simply Wall St.

7 months ago

Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

METALLA ANNOUNCES ANNUAL STOCK OPTION GRANT

PR Newswire

7 months ago

METALLA ANNOUNCES ANNUAL STOCK OPTION GRANT

Skeena Closes C$10.7 Million Flow-Through Financing

ACCESSWIRE

7 months ago

Skeena Closes C$10.7 Million Flow-Through Financing

Clearfield (NASDAQ:CLFD) shareholders have earned a 24% CAGR over the last five years

Simply Wall St.

7 months ago

Clearfield (NASDAQ:CLFD) shareholders have earned a 24% CAGR over the last five years

Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?

Motley Fool

7 months ago

Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?

3 Cannabis Stocks You’ll Regret Not Buying Soon: December Edition

InvestorPlace

7 months ago

3 Cannabis Stocks You’ll Regret Not Buying Soon: December Edition

VersaBank (NASDAQ:VBNK) Q4 2023 Earnings Call Transcript

Insider Monkey

7 months ago

VersaBank (NASDAQ:VBNK) Q4 2023 Earnings Call Transcript

Climb Channel Solutions Announces the Launch of a New Partnership with DNSFilter in North America

GlobeNewswire

7 months ago

Climb Channel Solutions Announces the Launch of a New Partnership with DNSFilter in North America

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Zacks

7 months ago

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

12 Extreme Dividend Stocks With Upside Potential

Insider Monkey

7 months ago

12 Extreme Dividend Stocks With Upside Potential

Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

CorpGov.com

7 months ago

Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024

PR Newswire

7 months ago

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024

Investors Title Company's (NASDAQ:ITIC) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

8 months ago

Investors Title Company's (NASDAQ:ITIC) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Hamilton Beach Brands Holding (NYSE:HBB) investors are sitting on a loss of 18% if they invested five years ago

Simply Wall St.

8 months ago

Hamilton Beach Brands Holding (NYSE:HBB) investors are sitting on a loss of 18% if they invested five years ago

Calculating The Fair Value Of FutureFuel Corp. (NYSE:FF)

Simply Wall St.

8 months ago

Calculating The Fair Value Of FutureFuel Corp. (NYSE:FF)

Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Data from the American Society of Hematology (ASH) 2023 Annual Meeting on December 13, 2023

GlobeNewswire

8 months ago

Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Data from the American Society of Hematology (ASH) 2023 Annual Meeting on December 13, 2023

PR Newswire

8 months ago

Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Clearfield (CLFD) Underperformed in Q3

Insider Monkey

8 months ago

Clearfield (CLFD) Underperformed in Q3

Renovaro BioSciences CEO Featured in Recent Proactive Interview

NewMediaWire

8 months ago

Renovaro BioSciences CEO Featured in Recent Proactive Interview

Implied Volatility Surging for Agora (API) Stock Options

Zacks

8 months ago

Implied Volatility Surging for Agora (API) Stock Options

The Zacks Analyst Blog Highlights Civeo, Hilton Grand Vacations and InterContinental Hotels

Zacks

8 months ago

The Zacks Analyst Blog Highlights Civeo, Hilton Grand Vacations and InterContinental Hotels

Angel Oak Mortgage REIT Inc CFO & Treasurer Brandon Filson Sells 24,371 Shares

GuruFocus.com

8 months ago

Angel Oak Mortgage REIT Inc CFO & Treasurer Brandon Filson Sells 24,371 Shares

CTO Realty Growth Declares Dividends for the Fourth Quarter 2023

GlobeNewswire

8 months ago

CTO Realty Growth Declares Dividends for the Fourth Quarter 2023

FutureFuel (NYSE:FF) investors are sitting on a loss of 39% if they invested five years ago

Simply Wall St.

8 months ago

FutureFuel (NYSE:FF) investors are sitting on a loss of 39% if they invested five years ago

Innodata to Participate in Needham's 4th Annual Virtual Tech Week

ACCESSWIRE

8 months ago

Innodata to Participate in Needham's 4th Annual Virtual Tech Week

Oculis Reports Q3 2023 Financial Results and Provides Company Update

GlobeNewswire

8 months ago

Oculis Reports Q3 2023 Financial Results and Provides Company Update

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Acumen Pharmaceuticals Inc Earnings Call

Share on Social Networks: